The “RADIANCE II” Pivotal Study A Study of the ReCor Medical Paradise System in Stage II Hypertension (CLN 0841) (Radiance-II)
The objective of the RADIANCE II Pivotal study is to demonstrate the effectiveness and safety of the Paradise System in subjects with Stage 2 hypertension on 0-2 medications at the time of consent. Prior to randomization, subjects will be hypertensive in the absence of hypertension medication.
RADIANCE-II